• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • 786-300-3183
  • [email protected]
  • Facebook
  • Twitter
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • Distinguished Service Award Past Recipients
      • President Engagement Award Past Recipients
      • FSA Past Presidents
    • FSA Staff
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • Annual Meeting
    • Meeting Info
    • Call For Abstracts
    • Past Posters
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to FSAPAC
    • FSAPAC 2020 Donor Honor Roll
    • FSAPAC 2019 Donor Honor Roll
  • Join/Renew Membership
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)
  • Member Login
  • Member Section
  • FSA Newsletter
  • Anesthesia 101
    • Made for this Moment
    • For Patients – Anesthesia 101
  • Partners

2019 FSA Posters

P010: PREDICTIVE VALUE OF NON-INVASIVE CARDIAC TESTING FOR PREOPERATIVE CORONARY REVASCULARIZATION AND ADVERSE CARDIAC EVENTS 30-DAYS POST KIDNEY TRANSPLANT
Nicholas V Mendez, MD, Raveh Yehuda, MD, Vadim Shatz, MD, Ramona Nicolau-Raducu, MD, PhD; University of Miami Miller School of Medicine

Introduction: Renal transplantation is associated with adverse perioperative cardiovascular outcomes and pretransplant cardiac evaluation is, therefore, indicated for high-risk candidates. The predictive value of non-invasive stress testing for preoperative coronary revascularization, and adverse outcomes in this high risk group is not well established.

Methods: After an IRB approval, out of 313 cadaveric kidneys transplanted between January 2016 to July 2017, we retrospectively identified 52 recipients whose pretransplant cardiac workup included both routine non-invasive stress (regadenoson nuclear 49; dobutamine 2; exercise stress test 1) and coronary angiography (18- due to positive stress test & 34- due to ≥3 risk factors for coronary artery disease). Pretransplant coronary revascularization was required in 33% (17/52; 14 percutaneous and 3 surgical coronary revascularization).

Results: Non-invasive testing had low sensitivity (47%) & positive predictive value (44%), and intermediate specificity (71%) & negative predictive value (74%) for detection of severe coronary artery stenosis (≥ 70%), Table 1. In the first post-transplant month, 11 adverse cardiac events (1 non-fatal and 1 fatal myocardial infarction, 5 atrial fibrillation, 4 pulmonary edema) occurred in 13% (7/52) of recipients. Preoperative non-invasive stress testing and coronary revascularization had an intermediate specificity (64%) and a relatively high negative predictive value (>80%) for prediction of 30-days post kidney transplant adverse cardiac events in high risk recipients, Table 1.

Conclusion: Preoperative revascularization does not fully protect against adverse cardiac outcomes; a positive non-invasive stress test result is not reliably indicative of an increased cardiac risk, but a negative result is strongly predictive of an uneventful posttransplant cardiovascular course.

Primary Sidebar

Subscribe for Email News

FSA Annual Meeting

REGISTER HERE For general information on the 2022 FSA Annual Meeting CLICK HERE. FSA 2022 Preliminary Program (as of April 8, 2022) Friday, … learn more... about FSA Annual Meeting

Call For Abstracts

If you have any questions, please contact the FSA … learn more... about Call For Abstracts

Copyright © 2022 Florida Society of Anesthesiologists · Managed by BSC Management, Inc.